πŸ“Š Biopharmaceutics and Pharmacokinetic
Q. The occurrence of food in the GI tract can affect the drug bioavailability from an oral drug product. The above give statement is?
  • (A) True
  • (B) False
  • (C) Both of the above
  • (D) None of the above
πŸ’¬ Discuss
βœ… Correct Answer: (A) True
πŸ“Š Biopharmaceutics and Pharmacokinetic
Q. When the solvent molecules are entrapped in the crystalline structure of the polymorph, it is called as
  • (A) Pseudo-polymorphism
  • (B) Amorphism
  • (C) Crystallinity
  • (D) All of the above
πŸ’¬ Discuss
βœ… Correct Answer: (A) Pseudo-polymorphism
πŸ“Š Biopharmaceutics and Pharmacokinetic
Q. ................mechanism is useful to describe charged or highly ionized drug molecules.
  • (A) Ion-pair transport
  • (B) Cellular transport
  • (C) Active transport
  • (D) Passive tr
πŸ’¬ Discuss
βœ… Correct Answer: (A) Ion-pair transport
πŸ“Š Biopharmaceutics and Pharmacokinetic
Q. ……………… involves the engulfment of small molecules or fluid.
  • (A) Endocytosis
  • (B) Pinocytosis
  • (C) Phagocytosis
  • (D) None of the above
πŸ’¬ Discuss
βœ… Correct Answer: (B) Pinocytosis
πŸ“Š Biopharmaceutics and Pharmacokinetic
Q. ………………is the process of movement of unchanged drug from the site of administration to the systemic circulation.
  • (A) Absorption
  • (B) Dissolution
  • (C) Distribution
  • (D) Elimination
πŸ’¬ Discuss
βœ… Correct Answer: (A) Absorption
πŸ“Š Biopharmaceutics and Pharmacokinetic
Q. Which of the following is not the characteristic of the carrier mediated transport system?
  • (A) Energy dependent
  • (B) Reach equilibrium
  • (C) Metabolically inhibited
  • (D) Structurally specific and saturable
πŸ’¬ Discuss
βœ… Correct Answer: (B) Reach equilibrium